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In this study, we describe the generation and charac-
terization of cloned human CD4+ T lymphocyte
populations that have in®ltrated into cutaneous, 2,4-
dinitrochlorobenzene-induced delayed type hyper-
sensitivity reactions in healthy human subjects. It is
shown that, in addition to T helper type 1 clones,
elevated numbers of regulatory T clones, producing
high levels of interleukin-10 and interleukin-5, but
no measurable interleukin-4, were isolated from
delayed type hypersensitivity reactions in four of six
donors. A subsequent challenge with 2,4-dinitro-
chlorobenzene of two donors from whom only few
interleukin-10-producing T cell clones had been gen-
erated after primary challenge, resulted in a decrease
in the frequency of T helper type 1 clones and a
strong increase in the number of interleukin-10-pro-
ducing T helper type 2 and regulatory T clones.
Culture supernatants from the latter cells, activated
with anti-CD3 and anti-CD28 monoclonal antibody,
inhibited alloantigen-mediated T cell proliferation
which was, partly dependent on interleukin-10, and
independent of transforming growth factor-b. In
addition, dendritic cells generated in vitro in the pres-
ence of these culture supernatants were impaired in
their ability to induce alloantigen-induced prolifera-
tive responses. Differential expression of transcripts
for the T1/ST2 molecule enabled a phenotypic
distinction between resting regulatory T cells and
T helper type 2 cells, but not between regulatory
T cells and T helper type 1 cells. This experimental
model provides a useful tool to isolate human
in¯ammatory and anti-in¯ammatory T cell subpopu-
lations and, furthermore, enables the study of the
kinetics of their appearance into delayed type hyper-
sensitivity reactions. Key words: allergy/cytokines/hap-
ten/human/interleukin-10/skin/T lymphocytes. J Invest
Dermatol 117:318±325, 2001
C
utaneous sensitization with haptens (small lipophilic
chemicals that become antigenic in combination with
carrier proteins and peptides present in the groove of
major histocompatibility antigens) (Martin et al,
1992), results in contact hypersensitivity which, like
delayed type hypersensitivity (DTH) reactions, is a local in¯am-
matory immune response mediated by T effector cells. It has been
demonstrated in experimental murine models that interferon (IFN)
-g and IFN-g-promoting cytokines, such as interleukin (IL)-12,
play an important part in the induction of DTH reactions following
sensitization to haptens, whereas contact hypersensitivity is down-
regulated by IL-4 and IL-10, as a result of their strong anti-
in¯ammatory activity (DiIulio et al, 1996; Xu et al, 1996). Results
from studies, using major histocompatibility complex class I and/or
class II de®cient mice, indicate that major histocompatibility
complex class I restricted, CD8+ T cells, rather than IFN-g-
producing CD4+ Th1 cells, are suf®cient for the induction of
contact hypersensitivity to the strongly sensitizing hapten dinitro-
¯uorobenzene (Bour et al, 1995). Although, initially, contact
hypersensitivity of humans to haptens such as nickel was thought to
be associated with the presence of CD4+ Th1 cells, generated from
peripheral blood and cutaneous biopsies from nickel-sensitive
patients (Sinigaglia et al, 1985; Kapsenberg et al, 1992), CD8+
effector T cell clones (Cavani et al, 1998), as well as IL-4-producing
nickel-speci®c Th2 cells (Werfel et al, 1997) have been isolated as
well. Moreover, it has been reported that allergic responses to
nickel in patients with allergic contact dermatitis are associated with
a decrease in IL-10 production (Cavani et al, 1998), suggesting that
the clinical outcome of contact sensitivity, following exposure to
hapten is determined by the balance between IFN-g-producing
CD8+ T effector cells and anti-in¯ammatory IL-4-and IL-10-
producing CD4+ T cells.
Recently, a unique population of CD4+ lymphocytes, desig-
nated T regulatory type 1 (Tr1) cells has been described (Groux et
al, 1997a). These cells, which have strong suppressive properties
and human Tr1 cells, are characterized by the high production of
IL-10 and IL-5, but absence of production of IL-4. In the mouse,
CD45RB+ Tr cells have been shown to play a crucial part in the
normal regulation of intestinal immune responses (reviewed in
Groux and Powrie, 1999). In addition, hapten-speci®c Tr-like
suppressor cells, isolated from mice following the application of
hapten to ultraviolet-irradiated skin were found to block the
induction of Th1-cell-mediated contact sensitivity in adoptive
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transfer experiments (Shreedhar et al, 1998). Apart from their
cytokine production pro®le and strong anti-in¯ammatory proper-
ties, little is known about the phenotypic characteristics of Tr cells,
in contrast to CD4+ Th1 and Th2 cells, which can be identi®ed
based on the presence or absence of expression of functional
receptors for IFN-g (Pernis et al, 1995; Groux et al, 1997b) and IL-
12 (Rogge et al, 1997; Szabo et al, 1997). In addition, an IL-1R-like
cell surface molecule, designated T1/ST2 (Klemenz et al, 1989;
Tominaga, 1989) has been reported to be involved in murine Th2
effector function, but its expression on human Th2 and Tr cells is
unknown (LoÈhning et al, 1998; Xu et al, 1998).
In this study, we have induced cutaneous DTH reactions in
healthy human subjects, following sensitization and challenge with
2,4-dinitrochlorobenzene (DNCB), with the aim of generating and
characterizing subpopulations of T cells that have migrated into the
site of in¯ammation. The use of this naive hapten permits the study
of the in vivo appearance of polarized subpopulations of T cells into
DTH reactions, whereas these cells upon cloning and expansion
can be used for a detailed functional and phenotypic characteriza-
tion.
MATERIALS AND METHODS
Sensitization and induction of DNCB-mediated cutaneous DTH
reactions Cutaneous DTH reactions were induced in healthy human
volunteers (without any form of atopic disease), after an initial
sensitization and a subsequent challenge with DNCB; this was done
according to a protocol, approved by the ethical commission of the
University Hospitals of Montpellier. During sensitization, a petrolatum-
backed 11 mm ®lter, containing 30 mg DNCB (Sigma/Aldrich
Chemicals, St Louis, MO), diluted in 50 ml acetone was placed within a
metal chamber (diameter 12 mm: Finn Chambers, PromeÂdical, La
ChausseÂe St Victor, France) and the assembly was immobilized with
hypoallergenic adhesive tape on the left buttock for 48 h. Fourteen days
after the initial sensitization, a DTH reaction was elicited; this was
following the application of 30 mg DNCB, diluted in acetone to the
inner side of the upper arm, opposite of the sensitization site, using a
7 mm petrolatum-backed ®lter disk and a 8 mm metal chamber (Finn
Chambers). Forty-eight hours after the challenge, the intensity of the
DTH reaction was determined, according to the guidelines of the
International Contact Dermatitis Group (Adams, 1981), and a 5 mm
punch biopsy from DTH reactions with a score > 3 was taken from the
site of in¯ammation. Scores were determined as follows: (1) no reaction;
(2) mild erythema; (3) moderate erythema, occasionally with papulation;
(4) strong erythematous reaction with edematous vesicular changes; and
(5) extreme of spreading reaction, including bullous or ulcerative
reactions. For kinetics studies, DNCB was applied twice on the inner
arm 14 d after the initial sensitization with an interval of 14 d between
the ®rst and the second challenge and again a punch biopsy was taken
48 h after the challenge. Punch biopsies were transferred to a 24-well
tissue culture plate (Linbro, McLean, VA) in a ®nal volume of 1 ml of a
culture medium (described by Yssel et al, 1984), supplemented with 1%
human AB+ serum and 2 ng per ml recombinant (r)IL-2 (a kind gift of
Dr Satish Menon, DNAX Research Institute, Palo Alto, CA) and
incubated at 37°C in 5% CO2. After 3 d of culture, fresh medium
containing 2 ng per ml rIL-2 was added to the cultures and growing
T cells were collected after 7 d of culture for cloning.
T cells Cultures of T cells, grown out of punch biopsies from DNCB-
induced DTH reactions, were cloned by limiting dilution in the
presence of 5 3 104 irradiated (90 Gy) allogeneic peripheral blood
mononuclear cells (PBMC), 5 3 103 irradiated (90 ) cells of the Epstein±
Barr virus-transformed B cell line JY and 0.1 mg per ml (Murex,
Beckenham, U.K.) in round-bottom wells of a 96-well tissue culture
plate (Nunc, Roskilde, Denmark), as described previously (Spits et al,
1982). After 5 d of culture, rIL-2 was added at a ®nal concentration of
2 ng per ml. Between 10 and 14 d after the cloning procedure, growing
T cell clones were analyzed for their cytokine production pro®le (see
below). Selected T cell clones were maintained in culture by weekly
stimulation with the feeder cell mixture referred to above (Spits et al,
1982). Three to 4 d after each restimulation, the cultures were expanded
in Yssel's medium, supplemented with 1% AB+ human serum and 2 ng
per ml rIL-2 and were used in experiments between 10 and 12 d after
the last stimulation with feeder cells.
PBMC were isolated from freshly collected, heparinized peripheral
blood (Center de Transfusion sanguine, Montpellier, France) by Ficoll-
Hypaque density gradient centrifugation. CD4+ peripheral blood T cells
were puri®ed (purity > 95%) by negative selection from mononuclear
cell preparations, using monoclonal antibody (MoAb)-coated magnetic
beads (StemCell Technologies, Vancouver, Canada), according to the
manufacturer's instructions.
Monocytes and dendritic cells Monocytes (purity > 95% CD14+)
were isolated from adherent PBMC (incubation at a concentration of
107 cells per ml at 37°C in Yssel's medium/1% human serum for 60 min
in a Petri dish) by negative selection using MoAb-coated magnetic beads
(Miltenyi Biotec, Bergisch Gladbach, Germany), according to the
manufacturer's instructions.
Immature dendritic cells were generated from monocytes cultured in
Iscove's modi®ed Dulbecco's medium (Life Technologies, Paisley, UK)
supplemented with 10% fetal bovine serum (Boehringer, Mannheim,
Germany), 200 ng per ml recombinant granulocyte-monocyte colony-
stimulating factor and 20 ng per ml rIL-4 (generous gifts from Drs
Gregorio Aversa, Novartis Research Institute, Vienna, Austria and N.
Nagabushan, Schering-Plough Research Institute, Kennilworth, NJ,
respectively), according to the method of Sallusto and Lanzavecchia
(1994). At day 6 of culture, lipopolysaccharide (Sigma) was added at a
concentration of 250 ng per ml for 24 h to induce maturation of the
cells. The resulting population of dendritic cells was predominantly
CD1a+, CD14±, CD83+, HLA-DR+ (Results not shown).
Analysis of cytokine production by enzyme-linked immunosorbent
assay (ELISA) Two hundred thousand T cell clones were transferred
to ¯at bottom wells of a 96 well culture plate (Nunc) and stimulated
with the immobilized, plate-bound, anti-CD3 MoAb SPV-T3b (Spits et
al, 1983) and anti-CD28 MoAb B-T3 (a kind gift of Dr John Wijdenes,
Diaclone, BesancËon). MoAb were coated at 4°C for 48 h on to the
culture plates at a concentration of 10 mg per ml in phosphate-buffered
saline and plates were washed twice with phosphate-buffered saline and
once with culture medium prior to the addition of cells. Control
supernatant was prepared following identical treatment in the absence of
T cells. After 24 h of culture, supernatants were harvested, spun at
270 3 g for 7 min to remove remaining cells, aliquoted, and stored at ±
20°C prior to cytokine measurements. Cytokine production was
analyzed by speci®c ELISA, as described previously (PeÁne et al, 1998).
For ELISA standards, preparations of puri®ed human rIL-4, rIL-5, and
rIFN-g were purchased from R&D Systems Europe (Abingdon, U.K.).
Production of IL-10 was measured using a commercial ELISA (Diaclone,
BesancËon, France), according to the manufacturer's instructions. Standard
curves for IL-4 and IFN-g were calibrated to reference samples from the
National Institute for Biological Standards and Control (NIBSC;
Hertfordshire, U.K.). The limits of sensitivity of the assays were about
5 pg per ml for each of the cytokines.
DNCB-induced and allo-antigen-induced proliferative
responses For the measurement of DNCB-speci®c responses, 105
T cell clones were stimulated with 90 g per ml DNCB sulfate (Sigma/
Aldrich in the presence of 105 autologous irradiated (50 Gy) PBMC. For
alloantigen-induced proliferative responses, 105 puri®ed CD4+ peripheral
blood T cells were incubated with 2.5 3 104 puri®ed irradiated (50 Gy)
monocytes from an HLA-DR mismatched healthy donor. Cultures were
carried out in 96 well round-bottom culture plates (Nunc), in the
absence or presence of different dilutions of culture supernatants
generated from activated T cell clones and neutralizing anti-IL10 MoAb
(B-N10, Diaclone Research) and/or the neutralizing anti-transforming
growth factor (TGF) -b MoAb 2G7 (a kind gift of Dr. Cees Melief,
Leiden University, the Netherlands), respectively, both at a ®nal
concentration of 10 mg per ml. As a control MoAb the anti-IL-5 MoAb
39D10 (kindly provided by Dr. John Abrams, DNAX Research
Institute, Palo Alto, CA) was used. To remove residual anti-CD3 and
CD28 MoAb, culture supernatants were incubated for 30 min at 4°C
with goat anti-mouse coated magnetic beads (Dynal), which were
subsequently removed using a magnetic separator.
Alternatively, CD4+ T cells were stimulated with dendritic cells
generated in vitro in the presence or absence of culture supernatants and
neutralizing anticytokine antibodies. Recombinant IL-10 (a generous gift
of Dr Nagabushan, Schering Plough Research Institute, Kennilworth,
NJ) was used as a positive control at a concentration of 10 ng per ml.
After 5 d of incubation at 37°C and 5% CO2, 37 kBq (1 mCi) of tritiated
thymidine (Amersham France, Les Ulis, France) was added to the
cultures. After another 8 h of culture, the cells were harvested on to glass
®ber sheets, using an automated cell harvester (Tomtec, Orange, CT) and
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radioactivity was measured, using a scintillation counter (Wallac, Turku,
Finland). Results are expressed as mean 6 SD of triplicate cultures.
cDNA synthesis and reverse transcription±polymerase chain
reaction (reverse transcription±PCR) analysis For analysis of IL-4,
IFN-g, IFN-gR b-chain, IL-12R b2-chain, and T1/ST2 mRNA
expression, 106 T cells were either cultured in medium alone or
stimulated with immobilized, plate-bound anti-CD3 MoAb and soluble
anti-CD28 MoAb for 6 h at 37°C, 5% CO2. At the end of each culture
period, the cells were harvested and spun for 5 min at 2703g After
removal of supernatant, the cell pellet was lyzed in RNAPlus (Quantum,
Illkirch, France), according to the manufacturer's instructions, and total
RNA was extracted using chloroform, precipitated with ethidium
bromide and quantitated by optical density readings at 260 nm. Reverse
transcription and ampli®cation of cDNA by PCR was performed as
described previously (Yssel and Cottrez, 1998). PCR cycles were 30 s at
94°C, 30 s at 60°C (48°C and 50°C for T1/ST2 and IL-12R b2-chain,
respectively), 30 s at 72°C, with 25 cycles for b-actin and 35 cycles for
IFN-g, IL-4, IFN-gR b-chain, IL-12R b2-chain, and T1/ST2. Primer
sequences used in this study are listed in Table I. PCR products were
analyzed on an ethidium bromide gel and scanned with a densitometer.
Immuno¯uorescence and ¯ow cytometry Immuno¯uorescence and
¯ow cytometry procedures were carried out using the method of Lanier
and Recktenwald (1991). Cell surface expression of CD4 was analyzed
using the phycoerythrin-conjugated Leu-3 MoAb (Becton-Dickinson,
San Jose, CA). Cell surface staining on dendritic cells was carried out
using the following MoAb: anti-CD1a (Immunotech, Lumigny, France),
anti-CD14, anti-CD83, and anti-HLA-DR (Becton Dickinson).
Immuno¯uorescence was analyzed on a FASCcalibur ¯ow cytometer
using Cellquest software (Becton Dickinson).
Statistical analysis Statistical analysis was performed by the Mann±
Whitney U test was used for intergroup analysis
RESULTS
Induction of a cutaneous DTH response in healthy donors
following sensitization and rechallenge with
DNCB Healthy human volunteers were sensitized following
the application of a ®xed dose of 30 mg of DNCB on to the skin
and were rechallenged with the same amount of DNCB 14 d later.
Forty-eight hours after the rechallenge, a local cutaneous
in¯ammation was observed in six of six patients, which was
characterized by an intensity score > 3. Punch biopsies, taken from
the DTH reactions, were cultured in the presence of 2 ng rIL-2 per
ml. Generally, between 5 3 105 and 106 T lymphocytes were
obtained after 7±10 d of culture.
Cytokine production pro®les of T cell clones obtained from
DNCB-induced DTH reactions Following cloning by
limiting dilution and expansion in vitro, the cytokine production
pro®le of T cell clones obtained from DNCB-induced DTH
reactions was analyzed. As is shown in Table II, a total of 839
CD4+ T cell clones obtained from six different donors were
analyzed for their capacity to produce IL-4, IL-5, IL-10, and IFN-
g, following stimulation of the cells with anti-CD3 and anti-CD28
MoAb. As expected, Th1 cells, producing IFN-g, but no IL-4, IL-
5, and secreting very low levels of IL-10 (< 100 pg per 106 cells),
could be isolated from the site of in¯ammation, although their
frequency varied among the different donors (Table II). The
frequency of Th2 cells, isolated from punch biopsies of four donors,
was very low and in one instance only (donor 1), a large number of
T cell clones expressing a Th2-like cytokine production pro®le was
generated, characterized by high levels of IL-4, IL-5, and IL-10
production. In addition, from the biopsies of three of six donors, a
signi®cant number of T cell clones were generated that produced
high levels of IL-10, but no detectable levels of IL-4; this resembled
a previously reported subpopulation of Tr cells (Groux and Powrie,
1999) with about 70% of T cell clones among the nearly 200 T cell
clones isolated from the skin biopsy of donor 4 expressing a Tr-like
Table I. List of primers used for RT-PCR
Gene
Direction
location Size cDNA Sequence
Annealing
temperature Cycles
b actin 5' 310 231 GCT GCT GAC CGA GGC CCC CCT GAA C 60 25
3' 541 CTC CTT AAT GTC ACG CAC GAT TTC 60
IL-4 5' 300 199 ACT CTG TGC ACC GAC TTG ACCGTA A 60 35
3' 499 TCT CAT GAT CGT CTT TAG CCT TTC C 60
IFN-g 5' 494 109 ATG AAA TAT ACA AGT TAT ATC TTG GCT TT 60 35
3' 603 GAT GCT CTT CGA CCT CGA AAC AGC AT 60
IFN-gR 5' 321 848 TTA AAT ACA CCG ACA GTA AAT GGT T 48 35
b chain 3' 1164 AAA GGC CGT GGA GGT ATC AGC GAT G 48
IL-12R 5' 214 992 ATC TTC GTT GGT GTT GC 50 35
b2 chain 3' 1189 GGG GTG AGG TTG ATT CC 50
ST2L 5' 393 ±17 CTT GAT TGA TAA ACA GAA TG 50 35
3' 376 CTG ATC CAG ATA CTG TTG AA 50
Table II. Number of T-cell clones obtained and phenotype











1 123 17 15 3 64 37
12.5 11.0 2.2 47.1 27.2
2 21 7 5 1 1 7
33.3 23.8 4.8 4.8 33.3
3 182 69 111 0 0 2
37.9 61.0 0.0 0.0 1.1
4 210 148 32 1 0 29
70.5 15.2 0.5 0.0 13.8
5 168 9 48 23 14 74
5.4 28.6 13.7 8.3 44.0
6 135 5 97 0 1 32
3.7 71.9 0.0 0.7 24.7
aNumbers and frequencies of T cell clones of each subpopulation indicated in
plain and bold/underlined numbers, respectively.
bProduction levels of T cell clones with a Tr phenotype de®ned as IL-10 >100
pg per ml, IL-4 < 10 pg per ml, IL-5 production > 1ng per ml; a Th1 phenotype
de®ned as IL-10 <100 pg per ml, IL-5 < 10 pg per ml, IL-4 < pg per ml or IFN-
g/IL-4 ratio > and a Th2 phenotype de®ned as IL-5 production > 1 ng per ml.
IFN-g < 20 pg per ml or IL-4/IFN-g ratio > 5; IL-10+ > 100 pg per ml;
IL-10+ >100 pg per ml; IL-10- < 100 pg per ml.
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cytokine production pro®le. Moreover, in keeping with results in
the literature (Bacchetta et al, 1990; Groux and Powrie, 1999), Tr
cells produced high levels of IL-5 (Table III, and results not
shown).
CD4+ Th0 clones, producing IL-4, IL-5, IFN-g, and variable
amounts of IL-10, were generated from four of six donors, with a
frequency between 14 and 40% of the total number of T cell clones
derived from DNCB-induced DTH reactions. Cloning ef®ciencies
of the limiting dilution assays were comparable (52±74%) with the
exception of one donor (donor 2) whose punch biopsy yielded only
22 T cell clones with a cloning ef®ciency of 29%. Among the T cell
clones obtained from donors 2, 3, 4, and 6, tested for reactivity
with DNCB sulfate, 16%, 25%, 7%, and 3%, respectively,
proliferated in response to stimulation with DNCB sulfate in the
presence of autologous irradiated PBMC.
Stability of T cell subpopulations obtained from cutaneous
DNCB-induced DTH reactions A number of the T helper
and Tr clones were selected and the stability of their cytokine
production pro®le upon prolonged culture was determined. As is
shown in Table III, none of the Tr clones produced IL-4, whereas
the production of IL-5 and IL-10 remained stable upon long-term
culture; however, the production of IFN-g in each of the Tr clones
increased over time. This phenomenon was also observed in some
of the strongly polarized Th2 clones that produced increasing
amounts of IFN-g, following repeated stimulation with feeder cells,
required for their maintenance in culture. This notion was
con®rmed by the analysis of IFN-g transcripts, which were
expressed at low levels in freshly generated, activated, Th2 and
Tr clones, but increasingly expressed by these cells following long-
term culture in vitro (Fig 3). In contrast, the cytokine production
pro®le of Th1 clones, obtained from cutaneous DNCB-induced
DTH reactions, remained stable and no induction of IL-10, IL-4,
or IL-5 was observed during prolonged culture of these cells
(Results not shown).
Repeated exposure to DNCB increases the number of IL-
10-producing Th2 and Tr cells in cutaneous DTH
reactions Because of the high frequency of IL-10-producing
Tr cells present in DTH reactions in donors that had been
sensitized and rechallenged only once with DNCB, we investigated
whether repeated exposure to this hapten speci®cally enhanced the
production of anti-in¯ammatory cytokines. To this purpose,
donors 5 and 6, from whom only 13.7% and 4.4%, respectively,
of Tr and IL-10-producing Th2 cells had been isolated, were
rechallenged with DNCB and the cytokine production pro®le of a
series of T cell clones isolated from a punch biopsy was analyzed
and compared with that of the ®rst series of clones. Analysis of the
cytokine production pro®le of individual T cell clones obtained
from donor 5, showed that the frequency of both Tr and IL-10-
producing Th2 cell clones had increased about 4-fold, whereas the
number of Th1 clones had decreased by 50% (Table IV). In
addition, a decrease of about 30% in the number of non-IL-10-
producing Th2 clones was observed as well. A similar increase in
the frequency of IL-10-producing Th2 (3.5-fold) and Tr (4.2-fold)
cells and a concomitant decrease in the frequency of Th1 cells (2-
fold decrease) generated from donor 6 was observed (Not shown).
Moreover, levels of IL-4 production by T cell clones generated
from the second biopsy from donor 5 were enhanced (644 6 463),
as compared with those following the ®rst challenge (218 6 360)
(Mann±Whitney, p < 0.001), whereas levels of IL-5 production
were only slightly affected (877 6 298 vs 655 6 432) (Mann±
Whitney, p < 0.001) (Fig 1); however, production levels of IFN-g
(1078 6 1470 vs 209 6 545) (Mann±Whitney, p < 0.001) and in
particular those of IL-10 (1070 6 913 vs 143 6 309) (Mann±
Whitney, p < 0.001) were strongly increased, as a result of an
additional challenge with DNCB.
Together, these results indicate that sensitization with DNCB
results in the induction of a DTH reaction, characterized not only
by the presence of in¯ammatory, IFN-g-producing Th1 cells, but
also of anti-in¯ammatory, IL-10 producing Tr and Th2 cells.
Moreover, although both the production of all cytokines increased,
following subsequent challenge with the same hapten, the most
signi®cant increase was observed with respect to the production of
IL-10 by IL-10-producing Th2 and Tr cells.
Culture supernatants from activated cutaneous DTH-
derived IL-10-producing Tr cells block alloantigen-
induced responses and inhibit in vitro differentiation of
dendritic cells To determine whether Tr clones, isolated from
DNCB-induced DTH reactions, were functionally active, culture
supernatants from these cells, activated for 24 h with immobilized
anti-CD3 and anti-CD28 MoAb, were tested for their capacity to
inhibit an alloantigen-induced proliferative response through their






Cytokine production (ng per ml)
Number of weeks in culture
5 7 9
HAT-B. 180 Tr IFN 0.9 4.1 7.0
IL-4 <0.01 <0.01 <0.01
IL-5 <0.01 <0.01 <0.01
IL-10 2.6 5.9 2.3
BOY-JF.161 Tr IFN 20.2 27.4 47.6
IL-4 <0.01 <0.01 <0.01
IL-5 4.6 34.1 17.2
IL-10 37.6 28.7 49.3
PUE.F3.46 Tr IFN 1.3 5.6 6.3
IL-4 <10 <10 <10
IL-5 15.7 18.2 16.8
IL-10 6.5 4.5 7.9
BOY-JF.157 Th2 IFN 0.08 0.04 0.1
IL-4 13.4 8.5 11.8
IL-5 218.0 77.0 120.0
IL-10 3.7 2.4 2.2
PUE.F3.9 Th2 IFN 0.02 1.2 3.5
IL-4 10.9 15.4 13.9
IL-5 15.6 12.0 9.8
IL-10 5.7 6.6 4.5
Table IV. Evolution of T cell clone cytokine production












1 168 9 48 23 14 74
5.4 28.6 13.7 8.3 44.0
2 153 32 17 13 50 41
20.9 11.1 8.3 32.7 26.8
aNumbers and frequencies of T cell clones of each subpopulation indicated in
plain and bold/underlined numbers, respectively.
bProduction levels of T cell clones with a Tr phenotype de®ned as IL-10 >100
pg per ml, IL-4 < 10 pg per ml, IL-5 production > 1 ng per ml; a Th1 phenotype
de®ned as IL-10 < 100 pg per ml, IL-5 < 10 pg per ml, IL-4 < pg per ml or
IFNg/IL-4 ratio > and a Th2 phenotype de®ned as IL-5 production > 1 ng per
ml. IFN-g < 20 pg per ml or IL-4/IFN-g ratio > 5; IL-10+ > 100 pg per ml;
IL-10+ >100 pg per ml; IL-10- < 100 pg per ml.
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production of IL-10 (Bejarano et al, 1992). Stimulation of T cells
with irradiated allogeneic PBMC induced a strong proliferative
response, measured after 5 d of culture, which was strongly
inhibited by the addition of Tr cell-derived culture supernatants
(Fig 2A). Addition of a neutralizing anti-IL-10 MoAb to the
cultures partly restored the proliferative response, whereas the
addition of a neutralizing anti-TGF-b MoAb, either alone, or in
combination with the anti-IL-10 MoAb had little effect. A culture
supernatant from an activated IL-10-producing Th2 clone also
inhibited the alloantigen-induced response (results not shown,
whereas culture supernatants from an activated Th1 clone were
ineffective (Fig 2A).
Moreover, the addition of culture supernatants from an activated
Tr clone affected the differentiation in vitro of dendritic cells from
peripheral blood monocytes by rIL-4 and recombinant granulo-
cyte-monocyte colony-stimulating factor, as indicated by a lower
expression levels of CD1a and CD83 (Results not shown).
Dendritic cells derived in the presence of culture supernatants
from activated Tr cells showed a strongly diminished capacity to
induce an antigen driven proliferative response (Fig 2B), suggest-
ing that the latter cells, via the production of soluble factors,
interfere with this process.
IL-10-producing Tr clones express transcripts for
cytokine receptors, but do not express T1/ST2
mRNA The expression of transcripts for the IFN-gR b-
chain, the IL-12R b2-chain and the IL-1R-homolog T1/ST2
was analyzed by reverse transcription±PCR, using representative
samples of T helper and Tr cell clones, in a resting state, as
well as following stimulation of the cells for 6 h with anti-CD3
and anti-CD28 MoAb. Transcripts for the IFN-gR b-chain
could be detected in activated and resting Th2 cell clones, but
were only very weakly expressed in resting Tr and Th1 clones
(Fig 3). Activation of both Th1 and Tr clones for 6 h with
anti-CD3 and anti-CD28 MoAb, however, resulted in an
induction of IFN-gR b-chain mRNA expression. Resting and
activated Th1 clones expressed transcripts for the IL-12R b2-
chain. Although transcripts for this receptor component were
low to undetectable in resting Th2 and Tr clones, activated
cells all expressed IL-12R b2-chain mRNA. By contrast,
expression of T1/ST2 transcripts was not detectable in any of
the resting T cell clones from the three subpopulations. T1/ST2
mRNA was only expressed in activated Th2 clones (Fig 3).
As expected, expression of IL-4 transcripts was only detected in
activated Th2 clones, but was undetectable in activated Th1 and
Tr1 clones (Fig 3). Reminiscent of results obtained by analyzing
cytokine production, activated Th1, Th2, and Tr clones expressed
variable levels of IFN-g transcripts, depending on the duration of
their time in culture.
Figure 1. Repeated exposure to DNCB increases the presence of
IL-10-producing Th2 and Tr cells in cutaneous DTH reactions.
Production of IL-4, IL-5, IFN-g and IL-10 was determined by ELISA in
culture supernatants of activated T cell clones, isolated from cutaneous
DTH reactions, following a single (1) or repeated (2) challenge of a
healthy donor with DNCB, which had been stimulated with
immobilized anti-CD3 and anti-CD28 MoAb for 24 h, as described in
Materials and Methods. p < 0.0001 (Mann±Whitney) increase in cytokine
production levels following (2) as compared with (1).
Figure 2. Cutaneous DTH-derived IL-10-producing T helper and
Tr cell clones are functionally active. One hundred thousand
puri®ed CD4+ T lymphocytes were stimulated with 2.5 3 104 puri®ed
allogeneic monocytes, in the presence or absence of either rIL-10,
culture supernatants from activated T cell clones (A)or with various
numbers of in vitro generated allogeneic dendritic cells (B), in the absence
or presence of neutralizing anti-IL-10, anti-TGF-b, or anti-IL-5 MoAb,
as described in Materials and Methods. Control supernatant was used to
verify whether all residual anti-CD3-and anti-CD28 MoAb had been
removed from the culture supernatants. Proliferative responses were
measured after 5 d by tritiated thymidine incorporation and expressed as
cpm 6 SD. Results of two independent experiments.
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DISCUSSION
Results reported in the literature, obtained in experimental mouse
and human models of in¯ammation, have indicated that hapten-
induced contact sensitivity reactions, are characterized by the
presence and the local effects of populations of T helper cells and Tr
cells with in¯ammatory and anti-in¯ammatory properties, respect-
ively. This study supports this notion by showing that, although
sensitization with the hapten DNCB induces strong cutaneous
DTH reactions, reportedly as a result of the recruitment of IFN-g-
producing CD8+ (Bour et al, 1995; Cavani et al, 1998; Kehren et al,
1999), and Th1 effector cells (Sinigaglia et al, 1985; Kapsenberg et
al, 1992), IL-10-producing CD4+ Th2 and Tr cell populations are
recruited to the site of in¯ammation as well.
Most studies on hapten-speci®c recruitment of T lymphocyte
populations in humans have been carried out in allergic patients
with contact sensitivity to nickel. The use of a naive hapten, such as
DNCB, however, which, in contrast to nickel, also induces strong
DTH reactions in healthy individuals, permits the study of kinetics
of appearance of T cell subpopulations in sites of cutaneous
in¯ammation, as a result of sensitization followed by a single or
multiple challenge (s) with the same hapten. As shown in this study,
IL-10 producing Tr cells could be isolated from cutaneous punch
biopsies, following sensitization and a single challenge with
DNCB, whereas a subsequent challenge resulted in an increase in
the frequency of these cells, as well as of IL-10-producing Th2
cells. Our results support those of Cavani et al (1998, 2000) who
reported that IL-10-producing nickel-speci®c T cell clones can be
isolated from the peripheral blood of allergic and nonallergic
individuals and the skin of patients allergic to nickel (Cavani et al,
2000). In addition, the latter group showed that these cells
produced higher levels of IL-10 and lower levels of IFN-g, as
compared with those isolated from patients with allergic contact
dermatitis to nickel (Cavani et al, 1998); this suggests that the lack
of contact sensitivity against nickel in nonallergic individuals
correlates with the presence of increased levels of IL-10.
Tr cells isolated from cutaneous in¯ammatory reactions were
functionally active through the production of IL-10 and possibly
other cytokines with immunoregulatory activity. Surprisingly, the
addition of a neutralizing anti-TGF-b MoAb did not interfere with
the suppressive effects of Tr-derived culture supernatants. TGF-b
reportedly is involved in the activity of (IL-4-producing) regulatory
Th3 cells (Chen et al, 1994), but it does not seem to be the major
suppressive cytokine produced by the (non-IL-4-producing) Tr
cells, described in our study that are reminiscent of those reported
by Groux et al (1997a). Culture supernatants from activated Tr
clones strongly decreased the capacity of in vitro generated dendritic
cells to induce allo-speci®c proliferative responses; however, this
was not due to a decrease in the expression of HLA-DR on these
cells as, unexpectedly, Tr cell-derived culture supernatants were
found to upregulate HLA class II expression (H. Yssel, unpublished
data), con®rming an earlier observation made by Cavani et al
(2000). It seems, therefore, that the suppressive effects exerted by
the Tr cells are mediated via downregulation of costimulatory
molecules on dendritic cells, rather than as a result of down-
regulation of HLA class II molecules (de Waal Malefyt et al, 1991).
No information is available at present as to whether the
magnitude of DNCB-induced contact sensitivity reactions is
correlated with the presence or absence of IL-10-producing cells.
As the immunosuppressive effects of Tr cells reportedly are antigen-
speci®c (Groux et al, 1997a; Akdis et al, 1998), the answer to this
question can only be resolved by studying cutaneous immune
responses, following multiple challenges with this hapten. It is
important to note, however, that, unlike nickel, DNCB is able to
induce strong cutaneous in¯ammatory reactions, even in the
presence of IL-10 producing cells, as demonstrated in our study.
Although only carried out in two individuals, a subsequent
challenge with DNCB was found to result in an increase in
production levels of all cytokines analyzed (the strongest being
observed in the production of IL-10), as well as an increase in the
frequency of IL-10-producing T helper and Tr cells. Whether
continued exposure to this hapten will result in a segregation of
individuals, able to mobilize increased numbers of Tr cells that will
suppress contact sensitivity reactions, and those who will eventually
become allergic to this hapten is dif®cult to address due to ethical
constraints and, therefore, falls outside the scope of this study.
It has been reported that in vitro-generated Tr cells are dif®cult to
maintain in culture (Groux et al, 1997a), which has been attributed
to the strong immunosuppressive properties of IL-10, as well as to
its ability to induce a state of nonresponsiveness in T cells (Groux et
al, 1996). Whereas levels of IL-10 production varied among the Tr
clones, a number of those maintained in culture produced high
levels of this cytokine, raising the possibility that they are insensitive
to the immunosuppressive effects of IL-10. Whether or not this is
due to the absence of a functional IL-10R remains to be
determined. Preliminary results indicate that IL-10-producing
cells can be detected by ELISPOT among skin-in®ltrating
lymphocytes, following short-term culture in the presence of rIL-
2 (J. PeÁne, unpublished observations) and their generation in vitro,
therefore, does not seem to be due to a preferential outgrowth,
although it cannot be excluded that their presence may have
growth-inhibiting effects on other T cell populations.
Although the cytokine production pro®le of the Tr and Th2
clones, isolated from DNCB-induced DTH reactions, was rela-
tively stable, most of these cells started to produce increasing
amounts of IFN-g upon prolonged culture. This is most likely to be
due to the culture conditions used to expand the cells, as the
cytokine environment, containing IL-12, IFN-a, IL-18 (Abbas et
al, 1996), and IL-23 (Oppmann et al, 2000), produced by peripheral
blood mononuclear cells used as feeders, exerts IFN-g-inducing
effects, to which activated T cell clones are responsive; this is
because of their likely expression of a functional receptor for IL-12
in an activated state (see below). In this respect, it is important to
use skin-derived cloned Tr and T effector cells as early as possible
for functional studies, following their generation from skin biopsies,
at the time that they still display a polarized cytokine production
pro®le.
It has been reported previously that human IL-12R b2-chain
mRNA expression is strongly downregulated following Th2
Figure 3. Expression of mRNA encoding IL-4, IFN-g, IFN-gR b-
chain, and IL-12R b2-chain in cutaneous DTH-derived Th1, Th2,
and Tr clones. T cell clones were cultured in medium or stimulated
with immobilized anti-CD3 and anti-CD28 MoAb for 6 h and the
expression of speci®c transcripts was analyzed by reverse transcription±
PCR, as described in Materials and Methods. T cell clones were used after
eight restimulations with feeder cells, with the exception of PUE.F3.9
(six restimulations) and HAT.B180 (four restimulations). Representative
results of three independent experiments. Primer sequences and size of
the ampli®ed products are shown in Table I.
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differentiation (Rogge et al, 1997); however, in the latter study the
effect of TCR/CD3 complex-mediated activation on the expres-
sion of this receptor component was not addressed. Surprisingly,
IL-12R b2-chain transcripts were not only detected in Th1, but
also in activated Th2 and Tr clones analyzed in this study. It must
be stressed, however, that the expression of transcripts for this
receptor and the IFN-gR b-chain has not been analyzed in a
quantitative way in our study and that detection of each of these
molecules at the cell surface is tedious because of their low
expression levels (Novelli et al, 1997; Rogge et al, 1999).
Nevertheless, the results presented here suggest that activated
Th2 cells express a functional IL-12R, as, both IL-12Rb1 (results
not shown; Rogge et al, 1997) and IL-12R b2-chain mRNA is
detected in these cells, whereas the observed induction of IFN-g
production during prolonged culture of the cells suggest that they
are indeed responsive to the IFN-g production-inducing effects of
IL-12. Taken together, it seems that the dynamic and transient
expression pro®le of the IFN-gR and IL-12R components is likely
to interfere with the usefulness of these surface molecules as
phenotypic markers.
Recently, it was reported that T1/ST2, an IL-1R receptor-like
molecule of the immunoglobulin superfamily (Klemenz et al, 1989;
Tominaga, 1989) is stably expressed on mouse Th2, but not on
Th1 cells and it has been suggested that the T1/ST2 molecule is
likely to play an important part in Th2 effector function (LoÈhning et
al, 1998; Xu et al, 1998). Transcripts encoding the T1/ST2
molecule could only be detected in human Th2 clones. None of
the Th1 and Tr clones expressed T1/ST2 mRNA, irrespective of
their state of activation and, therefore, do not express this molecule
at their cell surface. As at present no information is available on the
function and expression of human T1/ST2, the functional
implications of this observation cannot been evaluated.
As Th2 cells also produce IL-10, following antigen-speci®c
activation, there is a priori no precedence for a role of Tr cells as a
unique cell type producing this cytokine and it is unlikely that Th2-
derived IL-10 has different functional capacities as IL-10 produced
by Tr cells. Indeed, culture supernatants from IL-10-producing
Th2 clones effectively inhibited allo-antigen-induced proliferative
responses. Interestingly, however, Tr cells have been found to
localize speci®cally in the target organs, even in the absence of
antigenic activation (Groux, H., unpublished results), where they
suppress in¯ammation in the local microenvironment (Chen et al,
1994). It is, therefore, to be expected that the latter cells might have
a different make-up of adhesion molecules (and possibly chemokine
receptors) at their cell surface as compared with those on Th2 cells,
which might suggest that IL-10-producing Th2 cells are less
effective in exerting anti-in¯ammatory responses at the site of
in¯ammation.
In conclusion, the model described here, using a strong DTH-
inducing hapten to induce the migration of Tr cells into in¯amed
skin, is useful to isolate this T lymphocyte subpopulation and
enables further functional and phenotypic characterization to
understand their role in the control of in¯ammatory immune
responses.
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